Senseonics (NYSE:SENS) Upgraded to "Strong-Buy" at Lake Street Capital

Senseonics (NYSE:SENS - Get Free Report) was upgraded by investment analysts at Lake Street Capital to a "strong-buy" rating in a note issued to investors on Thursday,Zacks.com reports.

Several other equities research analysts have also commented on SENS. Wall Street Zen raised Senseonics to a "sell" rating in a research note on Monday, May 12th. TD Cowen began coverage on Senseonics in a report on Tuesday. They issued a "buy" rating and a $1.25 price target for the company. Mizuho began coverage on shares of Senseonics in a research report on Thursday, April 10th. They issued an "outperform" rating and a $2.00 price objective for the company. Finally, HC Wainwright reaffirmed a "buy" rating and set a $1.40 price target (up previously from $1.10) on shares of Senseonics in a research report on Tuesday, July 8th. One analyst has rated the stock with a sell rating, two have assigned a buy rating and two have given a strong buy rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Buy" and an average price target of $1.55.

Senseonics Stock Performance

Shares of SENS stock opened at $0.58 on Thursday. The stock has a market capitalization of $379.38 million, a PE ratio of -4.46 and a beta of 0.92. Senseonics has a 52-week low of $0.25 and a 52-week high of $1.40. The stock's 50-day moving average price is $0.52 and its 200 day moving average price is $0.68. The company has a quick ratio of 2.38, a current ratio of 2.47 and a debt-to-equity ratio of 59.17.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the business. Raymond James Financial Inc. purchased a new position in Senseonics during the 4th quarter worth approximately $26,000. IFP Advisors Inc boosted its stake in shares of Senseonics by 120.9% during the 1st quarter. IFP Advisors Inc now owns 47,500 shares of the company's stock valued at $31,000 after buying an additional 26,000 shares during the period. CTC Alternative Strategies Ltd. acquired a new stake in shares of Senseonics in the 1st quarter valued at $31,000. HighTower Advisors LLC acquired a new stake in shares of Senseonics in the 4th quarter valued at $32,000. Finally, Two Sigma Investments LP acquired a new stake in shares of Senseonics in the 4th quarter valued at $36,000. Institutional investors and hedge funds own 12.36% of the company's stock.

Senseonics Company Profile

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.